Protagonist Therapeutics Inc (PTGX)
EBITDA
$165.51M
Quarterly · Period ending: · USD
PTGX EBITDA
Latest reported$165.51Mperiod ending
Latest reported$165.51Mperiod ending
PTGX Quarterly EBITDA (-$2.63M → $165.51M)
Quarterly EBITDA
High-resolution chart · PNG
PTGX ebitda history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA (USD) |
|---|---|
| 165,511,000 | |
| 2,688,000 | |
| -43,342,000 | |
| -38,978,000 | |
| -34,295,000 | |
| -11,416,000 | |
| 134,200,000 | |
| -32,983,000 | |
| -29,816,000 | |
| 210,902,000 | |
| 28,167,000 | |
| -33,278,000 | |
| -37,639,000 | |
| -32,893,000 | |
| -31,696,000 | |
| -30,379,000 | |
| -40,194,000 | |
| -20,097,000 | |
| -36,988,000 | |
| -33,100,000 | |
| -30,214,000 | |
| -23,397,000 | |
| -18,198,000 | |
| -7,146,000 | |
| -17,438,000 | |
| -19,000,000 | |
| -14,285,000 | |
| -15,872,000 | |
| -30,183,000 | |
| -13,331,000 | |
| -15,284,000 | |
| -9,238,000 | |
| -9,069,000 | |
| -8,151,000 | |
| -3,396,000 | |
| -4,872,000 | |
| -15,038,000 | |
| -14,185,000 | |
| -11,322,000 | |
| -7,055,000 | |
| -7,005,000 | |
| -6,967,000 | |
| -4,914,000 | |
| -3,972,000 | |
| -3,030,000 | |
| -2,631,000 |